-
-
-
Open for Registration: The 3rd China-ASEAN Innovation and Entrepreneurship Competition (CAIEC-3) 2025
KUALA LUMPUR,Malaysia,Feb. 10,2025-- 2025 China – ASEAN Innovation and Entrepreneurship Competition is now calling for applications.
TusStar Malaysia / 02-13
-
-
-
-
Alexandra Hospital develops world's novel A.I. algorithm (with international patent) that enhances accuracy and efficiency of robotic total knee replacement
Newspoints: An A.I. algorithm for robotic total knee replacement (rTKR) has secured an international Patent Cooperation Treaty (PCT) patent[1],that protects this algorithm for robotic total knee repl
Alexandra Hospital (AH) / 02-13
-
-
-
-
Rees Ward Transitions into Key Leadership Role at Bridgewest Group as Operating Partner and General Manager, New Zealand
MIAMI and AUCKLAND,New Zealand,Feb. 12,2025-- Global private investment firm,Bridgewest Group,recognized for developing innovative companies in life sciences,software,and deep tech,is pleased to anno
Bridgewest Group / 02-13
-
-
-
-
From O Levels to a Medicine, Dentistry or Law Degree in Just 9 Months
SINGAPORE,Feb. 11,2025-- With the growing demand for doctors,Singapore has increased the number of recognised foreign medical schools and ambitious students aiming for careers in medicine,dentistry or
-
-
-
-
NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcare
Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM.
Paradromics / 02-13
-
-
-
-
Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC
HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult
Akeso, Inc. / 02-13
-
-
-
-
WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year
Ranked among the top 1% of companies assessed in the pharmaceutical industry Recognized as a leader in Green CRDMO,driving innovation for a healthier future
-
-
-
-
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints
CBL-514,the world\'s first investigational drug for large-area localized fat reduction,has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3.
-
-
-
-
SunCar Technology Group Integrates DeepSeek AI, Revolutionizing Automotive Service Intelligence
NEW YORK,Feb. 10,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (Nasdaq: SDA),an innovative leader in cloud-based B2B auto services and auto e-insurance in China,t
-
-
-
-
Permascand and Magneto Special Anodes merge to create a global leader in the advanced electrochemical sector - David Ekberg joins as CEO of the new company
LJUNGAVERK,Sweden,Feb. 10,2025-- Swedish-basedPermascand,owned by Altor,has merged with Magneto Special Anodes to form a global leader in catalytic coatings and electrodes for premium segment customer
-
Intelligent
Newest
